Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Large burns open up a can of worms

next article
23.08.2007

Large burns can trigger cardiac problems and enhanced inflammatory and hypermetabolic responses in patients, a study in the online open access journal Critical Care suggests. Effective treatments may need to focus on these multiple aspects.

 

Burns trigger an immediate, dramatic inflammatory response, as well as a more delayed and longer-lasting hypermetabolic one. The latter can cause depletion of essential proteins, reduced bone density and muscle strength, and can compromise the function of vital organs. But whilst it’s well known that increased burn size leads to increased mortality in burned patients, the roles played by inflammation and hypermetabolism are less clear.


Marc G. Jeschke from Shriners Hospitals for Children, Texas, USA and colleagues conducted a prospective clinical trial of 189 paediatric burned patients over nine years to see if burn size is associated with differences in inflammation, body composition, protein synthesis and organ function.

Burn injuries involving more than 80% of the total body surface cause marked and prolonged inflammation, increases in hypermetabolism, catabolism, cardiac dysfunction and subsequently higher incidences of infection, sepsis and death. These effects were burn size-dependent. Another outstanding finding was that effect of burn size on cardiac dysfunction. Only large burns caused cardiac dysfunction which was shown by Pereira et al. as one of the major contributor to mortality, implying the importance of adequate cardiovascular support and treatment.

Patients with larger burns also had higher levels of pro-inflammatory cytokines, such as Tumor Necrosis Factor and Interleukin-8. The authors think these give the inflammatory response an added boost, enhancing catabolism and hypermetabolism.

Charlotte Webber | Source: alphagalileo
Further information: www.biomedcentral.com

next article

More articles from Health and Medicine:

nachricht Towards Improved Immunotherapy
01.12.2008 | Elsevier

nachricht First trial in patients with a potential treatment of the incurable ALS muscle disease
01.12.2008 | VIB, the Flanders Institute for Biotechnology

B2B Search

Product / Service
Company / Organisation

Latest News

Wilkins Ice Shelf under threat

01.12.2008 | Earth Sciences

A picture paints more than a petabyte of data

01.12.2008 | Physics and Astronomy

Sex life of killer fungus finally revealed

01.12.2008 | Life Sciences

Event News

Dublin to host Europe’s largest interdisciplinary science conference in 2012

28.11.2008 | Event News

ECREA Barcelona 2008

28.11.2008 | Event News

The Automobile – The Transition from Energy Guzzler to Power Supplier

20.11.2008 | Event News